3 resultaten
OBJECTIVE
In patients with symptomatic diabetic polyneuropathy, is oral alpha-lipoic acid (ALA) effective in improving neuropathic symptoms compared with placebo?
METHODS
The question was addressed with a structured evidence-based clinical neurologic practice review via videoconferencing between 3
OBJECTIVE
The aim of this trial was to evaluate the effects of alpha-lipoic acid (ALA) on positive sensory symptoms and neuropathic deficits in diabetic patients with distal symmetric polyneuropathy (DSP).
METHODS
In this multicenter, randomized, double-blind, placebo-controlled trial, 181 diabetic
BACKGROUND
The etiopathogenetic mechanisms of peripheral neuropathies include genetic, traumatic, toxic, metabolic, infectious, nutritional, inflammatory and paraneoplastic causes. Their treatment should primarily address their contributing causes. However, symptomatic therapy is also key in these